We are live on ! Find out more
CDR

Clayton Dubilier & Rice Portfolio holdings

AUM $895M
1-Year Est. Return 792.56%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+792.56%
3 Year Est. Return
+175.84%
5 Year Est. Return
+204.57%
10 Year Est. Return
+288.13%
AUM
$3.72B
AUM Growth
-$1.7B
Cap. Flow
-$2.06B
Cap. Flow %
-55.39%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CNM icon
Core & Main
CNM
+$1.67B
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$392M

Sector Composition

Rank Sector Weight
1 Industrials 66.16%
2 Healthcare 33.69%
3 Consumer Discretionary 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNM icon
1
Core & Main
CNM
$8.25B
$2.01B 53.92%
49,696,744
-49,385,422
-50% -$1.67B
AGL icon
2
Agilon Health
AGL
$1.61B
$1.25B 33.69%
4,000,000
BECN
3
DELISTED
Beacon Roofing Supply, Inc.
BECN
$456M 12.24%
5,241,030
-5,000,000
-49% -$392M
GPK icon
4
Graphic Packaging
GPK
$3.38B
$5.3M 0.14%
214,935
FTDR icon
5
Frontdoor
FTDR
$5.75B
$177K ﹤0.01%
5,034

Similar funds

Clayton Dubilier & Rice's Q4 2023 Portfolio in Review

As of Q4 2023, Clayton Dubilier & Rice held 5 positions worth $3.72B, down 31% from $5.43B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Clayton Dubilier & Rice withdrew a net $2.06B in Q4 2023, reducing 2 holdings. Its largest reduction was Core & Main, cutting an estimated $1.67B.

By sector, the portfolio is most concentrated in Industrials at 66% of assets, down from 67% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Clayton Dubilier & Rice's biggest Q4 2023 reduction was Core & Main, cutting an estimated $1.67B.
  • Clayton Dubilier & Rice's ten largest holdings make up 100% of its $3.72B portfolio in Q4 2023.
  • Clayton Dubilier & Rice opened 0 new positions and closed 0 in Q4 2023.
  • Clayton Dubilier & Rice's portfolio value fell 31% quarter-over-quarter to $3.72B.

Based on Clayton Dubilier & Rice's 13F filing for Q4 2023, filed 12 Feb 2024.